Sartorius AG

Global Cell and Gene Therapy Manufacturing QC Market Expected to Reach $10.65 Billion by 2033, Witnessing a CAGR of 16.85% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 16, 2023
Biotechnology, Genetics, Health, Gene, QC, NGS, Sartorius AG, Chromatography, Merck Group, MEA, Medicine, Research, Mass spectrometry, ELISA, Organization, Information International, Inc., CAR, QRM, Thermo Fisher Scientific, Patient safety, Flow cytometry, Kidney, Cell, PAT, LAL, Center for Urban and Regional Analysis, Electrophoresis, Therapy, Benchmarking, Eurofins Scientific, PCR, Safety, Automation, LATAM, Fine chemical, Pharmaceutical industry

The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is projected to reach $10.65 billion by 2033, with a CAGR of 16.85% during the forecast period from 2023 to 2033.
  • The demand for QC in cell and gene therapy manufacturing is driven by the growing production of therapies and increasing approvals for cell and gene therapies.
  • The global cell and gene therapy manufacturing QC market is on a growth trajectory, and key players are leveraging advancements in technology to drive improvements in product quality and safety.

Flow Cytometry Market worth $7.0 billion | MarketsandMarkets

Retrieved on: 
Wednesday, August 9, 2023
BioLegend, PlayStation Portable system software, Disease, Drug development, Drug discovery, Cancer research, Sartorius AG, Personalized medicine, Functional analysis, Research, Medicine, Agilent Technologies, Cell, Automation, Miniaturization, Disulfiram-like drug, Danaher Corporation, Transplant, Neuroscience, Acquisition, Laboratory, Machine learning, Microbiology, Flow cytometry, Apoptosis, Cell cycle, Hematology, Miltenyi Biotec, Luminex Corporation, SPS, Robotics, AI, B cell, Sony, Behavior, Sysmex Corporation, Computer data storage, Mobile phone, Pharmaceutical industry, Medical imaging

In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.

Key Points: 
  • In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.
  • In May 2023, Sysmex launched Clinical Flow Cytometry System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan.
  • Personalized Medicine: Flow cytometry contributes to personalized medicine by enabling tailored treatments based on individual patient profiles and disease characteristics.
  • These pointers highlight the multifaceted advantages of flow cytometry, making it an indispensable tool in scientific research, clinical diagnostics, and healthcare innovation.

Flow Cytometry Market worth $7.0 billion | MarketsandMarkets

Retrieved on: 
Wednesday, August 9, 2023
BioLegend, PlayStation Portable system software, Disease, Drug development, Drug discovery, Cancer research, Sartorius AG, Personalized medicine, Functional analysis, Research, Medicine, Agilent Technologies, Cell, Automation, Miniaturization, Disulfiram-like drug, Danaher Corporation, Transplant, Neuroscience, Acquisition, Laboratory, Machine learning, Microbiology, Flow cytometry, Apoptosis, Cell cycle, Hematology, Miltenyi Biotec, Luminex Corporation, SPS, Robotics, AI, B cell, Sony, Behavior, Sysmex Corporation, Computer data storage, Mobile phone, Pharmaceutical industry, Medical imaging

In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.

Key Points: 
  • In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.
  • In May 2023, Sysmex launched Clinical Flow Cytometry System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan.
  • Personalized Medicine: Flow cytometry contributes to personalized medicine by enabling tailored treatments based on individual patient profiles and disease characteristics.
  • These pointers highlight the multifaceted advantages of flow cytometry, making it an indispensable tool in scientific research, clinical diagnostics, and healthcare innovation.

EQS-News: SARTORIUS AG: Florian Funck appointed CFO of Sartorius

Retrieved on: 
Thursday, August 3, 2023
Vaccine, Funck, Haniel, Sartorius AG, Supervisory board, Research, Business administration, RTÉ Executive Board, Acquisition, Laboratory, Quality control, CFO, Growth, Sartorius, News, Security (finance), Management

At today’s meeting, the Supervisory Board of Sartorius AG appointed Dr. Florian Funck as Chief Financial Officer (CFO) and member of the Sartorius Executive Board, effective April 1, 2024.

Key Points: 
  • At today’s meeting, the Supervisory Board of Sartorius AG appointed Dr. Florian Funck as Chief Financial Officer (CFO) and member of the Sartorius Executive Board, effective April 1, 2024.
  • Funck joins the company from his current role as CFO of the Haniel Group, where he has been working for more than two decades.
  • After Lehmann’s departure and until Funck takes over, Sartorius CEO Dr. Joachim Kreuzburg will assume these responsibilities on an interim basis.
  • "We are very pleased to welcome Florian Funck as the new CFO of Sartorius in a few months’ time.

Global Single Use Bioreactors Research Report 2023-2028: Startups and SMEs Embrace Single-Use Bioreactors - Adoption Surges as Complexity Decreases - ResearchAndMarkets.com

Retrieved on: 
Monday, July 31, 2023
Biotechnology, Pharmaceutical, Health, Biometrics, Molecule, Hook effect, CMOS, Sartorius AG, Research, Thermo Fisher Scientific, USD, Danaher Corporation, Bioreactor, Government, Pulse, Merck Millipore, Investment, Water, Filtration, Growth, Region, ChromeOS, SME, Fine chemical, Landfill, Vaccine

The major factors driving the growth of this market include the increasing adoption of single-use bioreactors among startups and SMEs, reduced operational complexity of single-use bioreactors compared to conventional bioreactors, lower energy and water consumption, growing biologics and biosimilars market, and technological advancements in single-use bioreactors.

Key Points: 
  • The major factors driving the growth of this market include the increasing adoption of single-use bioreactors among startups and SMEs, reduced operational complexity of single-use bioreactors compared to conventional bioreactors, lower energy and water consumption, growing biologics and biosimilars market, and technological advancements in single-use bioreactors.
  • This report provides a detailed picture of the single-use bioreactors market.
  • Based on application, the single-use bioreactors market is segmented into research & development, process development, and bioproduction.
  • Based on end users, the single-use bioreactors market is segmented into pharmaceutical & biotechnology companies, CROs & CMOs, and academic & research institutes.

Sartorius Stedim Biotech SA: Information on Document Availability

Retrieved on: 
Friday, July 21, 2023
Regulatory News Service, Sartorius AG, Fine chemical

The report on the first half 2023 results of Sartorius Stedim Biotech Group (Paris: DIM) is now available at:

Key Points: 
  • The report on the first half 2023 results of Sartorius Stedim Biotech Group (Paris: DIM) is now available at:
    It contains the following information:
    Consolidated financial statements for the period ended June 30, 2023
    Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry.
  • As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically.
  • Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris.
  • With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.

EQS-News: SARTORIUS AG: Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023

Retrieved on: 
Friday, July 21, 2023
Quotient, Vaccine, Research, ID Labs production discography, Sartorius AG, Forecasting, Public expenditure, CAPEX, EBITDA, Acquisition, CEST, RTÉ Executive Board, CFO, Environment, Sartorius, Security (finance), Retail, Fine chemical, Arms industry, Pharmaceutical industry, Music, Management

Accordingly, the company recorded a decline in sales revenue in the first six months of the year and a lower but still relatively high profitability.

Key Points: 
  • Accordingly, the company recorded a decline in sales revenue in the first six months of the year and a lower but still relatively high profitability.
  • We however expect orders to gradually pick up in the course of the second half of the year.
  • As expected, normalization of demand continued across all regions in the second quarter and therefore dominated the first half of 2023 overall.
  • Company management confirms its 2023 sales revenue and profitability outlook, which was adapted in June 2023.

Label-free Detection Market worth $863 million | MarketsandMarkets

Retrieved on: 
Thursday, July 20, 2023
Maintenance, SPR, Food safety, Shimadzu, Hazardous waste, Sartorius AG, Research, Gesellschaft mit beschränkter Haftung, Environmental monitoring, PerkinElmer, Risk, Agilent Technologies, Drug discovery, Waters Corporation, Kinetics, Artifact, Sartorius, Medical imaging, Microscope, Malvern Panalytical

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593
    Real-time analysis: Label-free detection techniques provide instant and continuous monitoring of molecular interactions, allowing researchers to observe dynamic processes in real-time.
  • Sensitivity and specificity: Label-free detection systems offer high sensitivity and specificity, enabling the detection of low concentrations of analytes in complex biological or environmental samples.
  • Wide range of applications: Label-free detection technology finds applications in various fields, including life sciences (biological interactions, protein-protein interactions, etc.
  • ), pharmaceuticals (drug discovery and development), food safety (detection of contaminants), and environmental monitoring (water quality analysis, pollutant detection), among others.

Label-free Detection Market worth $863 million | MarketsandMarkets

Retrieved on: 
Thursday, July 20, 2023
Maintenance, SPR, Food safety, Shimadzu, Hazardous waste, Sartorius AG, Research, Gesellschaft mit beschränkter Haftung, Environmental monitoring, PerkinElmer, Risk, Agilent Technologies, Drug discovery, Waters Corporation, Kinetics, Artifact, Sartorius, Medical imaging, Microscope, Malvern Panalytical

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593
    Real-time analysis: Label-free detection techniques provide instant and continuous monitoring of molecular interactions, allowing researchers to observe dynamic processes in real-time.
  • Sensitivity and specificity: Label-free detection systems offer high sensitivity and specificity, enabling the detection of low concentrations of analytes in complex biological or environmental samples.
  • Wide range of applications: Label-free detection technology finds applications in various fields, including life sciences (biological interactions, protein-protein interactions, etc.
  • ), pharmaceuticals (drug discovery and development), food safety (detection of contaminants), and environmental monitoring (water quality analysis, pollutant detection), among others.

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus

Retrieved on: 
Tuesday, July 18, 2023
Transfection, Euronext Paris, Euronext, Acquisition, Sartorius AG, Fine chemical

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has successfully closed the acquisition of the French company Polyplus.

Key Points: 
  • Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has successfully closed the acquisition of the French company Polyplus.
  • This press release contains forward-looking statements about the future development of the Sartorius Stedim Biotech Group.
  • Sartorius Stedim Biotech assumes no liability for updating such statements in light of new information or future events.
  • Sartorius Stedim Biotech delivers significant organic growth and regularly expands its portfolio through acquisitions of complementary technologies.